286 related articles for article (PubMed ID: 34143800)
1. Identification and analysis of genes associated with epithelial ovarian cancer by integrated bioinformatics methods.
Gui T; Yao C; Jia B; Shen K
PLoS One; 2021; 16(6):e0253136. PubMed ID: 34143800
[TBL] [Abstract][Full Text] [Related]
2. Prospective pathway signaling and prognostic values of MicroRNA-9 in ovarian cancer based on gene expression omnibus (GEO): a bioinformatics analysis.
Zuo L; Li X; Tan Y; Zhu H; Xiao M
J Ovarian Res; 2021 Feb; 14(1):29. PubMed ID: 33563317
[TBL] [Abstract][Full Text] [Related]
3. Data Mining of Differentially Expressed Genes in Ovarian Epithelial Carcinoma: Implications in Precise Medicine.
Zhao J; Gao H; He Y
Curr Top Med Chem; 2021 Oct; 21(14):1285-1300. PubMed ID: 34238161
[TBL] [Abstract][Full Text] [Related]
4. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
[TBL] [Abstract][Full Text] [Related]
5. Prognostic values and prospective pathway signaling of MicroRNA-182 in ovarian cancer: a study based on gene expression omnibus (GEO) and bioinformatics analysis.
Li Y; Li L
J Ovarian Res; 2019 Nov; 12(1):106. PubMed ID: 31703725
[TBL] [Abstract][Full Text] [Related]
6. Cross‑validation of genes potentially associated with neoadjuvant chemotherapy and platinum‑based chemoresistance in epithelial ovarian carcinoma.
Zhang K; Wang W; Chen L; Liu Y; Hu J; Guo F; Tian W; Wang Y; Xue F
Oncol Rep; 2020 Sep; 44(3):909-926. PubMed ID: 32705213
[TBL] [Abstract][Full Text] [Related]
7. Gene expression profiles and pathway enrichment analysis to identification of differentially expressed gene and signaling pathways in epithelial ovarian cancer based on high-throughput RNA-seq data.
Siavoshi A; Taghizadeh M; Dookhe E; Piran M
Genomics; 2022 Jan; 114(1):161-170. PubMed ID: 34839022
[TBL] [Abstract][Full Text] [Related]
8. Identification and analysis of genes associated with head and neck squamous cell carcinoma by integrated bioinformatics methods.
Jin Y; Yang Y
Mol Genet Genomic Med; 2019 Aug; 7(8):e857. PubMed ID: 31304688
[TBL] [Abstract][Full Text] [Related]
9. Identification of molecular marker associated with ovarian cancer prognosis using bioinformatics analysis and experiments.
Zheng MJ; Li X; Hu YX; Dong H; Gou R; Nie X; Liu Q; Ying-Ying H; Liu JJ; Lin B
J Cell Physiol; 2019 Jul; 234(7):11023-11036. PubMed ID: 30633343
[TBL] [Abstract][Full Text] [Related]
10. Identification of Differentially Expressed Genes (DEGs) Relevant to Prognosis of Ovarian Cancer by Use of Integrated Bioinformatics Analysis and Validation by Immunohistochemistry Assay.
Zhang L; Sun L; Zhang B; Chen L
Med Sci Monit; 2019 Dec; 25():9902-9912. PubMed ID: 31871312
[TBL] [Abstract][Full Text] [Related]
11. Identification of key molecular markers in epithelial ovarian cancer by integrated bioinformatics analysis.
Qin W; Yuan Q; Liu Y; Zeng Y; Ke D; Dai X; Shuai Y; Hu J; Shi H
Taiwan J Obstet Gynecol; 2021 Nov; 60(6):983-994. PubMed ID: 34794761
[TBL] [Abstract][Full Text] [Related]
12. Identification of potential markers for differentiating epithelial ovarian cancer from ovarian low malignant potential tumors through integrated bioinformatics analysis.
Hao W; Zhao H; Li Z; Li J; Guo J; Chen Q; Gao Y; Ren M; Zhao X; Yue W
J Ovarian Res; 2021 Mar; 14(1):46. PubMed ID: 33726773
[TBL] [Abstract][Full Text] [Related]
13. A bioinformatics analysis: ZFHX4 is associated with metastasis and poor survival in ovarian cancer.
Zong S; Xu PP; Xu YH; Guo Y
J Ovarian Res; 2022 Aug; 15(1):90. PubMed ID: 35915456
[TBL] [Abstract][Full Text] [Related]
14. Four genes relevant to pathological grade and prognosis in ovarian cancer.
Pan X; Chen Y; Gao S
Cancer Biomark; 2020; 29(2):169-178. PubMed ID: 32444534
[TBL] [Abstract][Full Text] [Related]
15. Exploration of the sequential gene changes in epithelial ovarian cancer induced by carboplatin via microarray analysis.
Wei S; Liu J; Shi Y; Zhang X; Yang Y; Song Q
Mol Med Rep; 2017 Sep; 16(3):3155-3160. PubMed ID: 28713952
[TBL] [Abstract][Full Text] [Related]
16. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis.
Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X
Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116
[TBL] [Abstract][Full Text] [Related]
17. Screening and validating the core biomarkers in patients with pancreatic ductal adenocarcinoma.
Li Y; Zhu YY; Dai GP; Wu DJ; Gao ZZ; Zhang L; Fan YH
Math Biosci Eng; 2019 Nov; 17(1):910-927. PubMed ID: 31731384
[TBL] [Abstract][Full Text] [Related]
18. Gene expression profiling of epithelial ovarian cancer reveals key genes and pathways associated with chemotherapy resistance.
Zhang M; Luo SC
Genet Mol Res; 2016 Jan; 15(1):. PubMed ID: 26909918
[TBL] [Abstract][Full Text] [Related]
19. Identification and validation of key genes with prognostic value in non-small-cell lung cancer via integrated bioinformatics analysis.
Wang L; Qu J; Liang Y; Zhao D; Rehman FU; Qin K; Zhang X
Thorac Cancer; 2020 Apr; 11(4):851-866. PubMed ID: 32059076
[TBL] [Abstract][Full Text] [Related]
20. Identification of Biomarkers for Ovarian Cancer Diagnosis and Prognosis by Bioinformatics Analysis and q-PCR Validation.
Zheng Q; Ye H; Zhong H; Wang M
Ann Clin Lab Sci; 2022 Nov; 52(6):967-975. PubMed ID: 36564071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]